Floatz logo

1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER

Lumbosacral Radiculopathy

Johns Hopkins Universityprotein_peptidePhase 2/3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

19 Active assets in the Lumbosacral Radiculopathy cohort.

Asset / SponsorPhaseRating
LIDOCAINE
C.L.A.Vleggeert-Lankamp
Phase 4BBB
DEXAMETHASONE
University of Miami
Phase 4BBB
NEPENTHE
Akdeniz University
Phase 4BB
Naproxen
Ostfold Hospital Trust
Phase 4BB
(RS)-KETOPROFEN
University Hospital, Grenoble
Phase 4BB

View all 45 →

Same molecule, other indications

1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER is also rated in:

psoriasisDormant
BBB
Indicative ·
76 / 100
View asset →
Pancreatitis, Chronic; Diabetes; TransplantDormant
BB
Indicative ·
68 / 100
View asset →
skin carcinomaDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →